Cytori’s Celution One system, intended for hospitals as a platform device with life-critical applications across multiple specialties, has been granted the CE Mark.

Celution One is the next-generation device of the company’s Celution platform, which is a GMP-compliant technology that extracts and concentrates a patient’s own stem and progenitor cells from adipose at the point of care.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Celution One is designed to improve cell yield, processing volumes and processing times, and the versatility and efficiency of potential treatments.

Cytori CEO Christopher Calhoun said it is using the Celution One in pivotal heart attack trial ADVANCE, and aim of expand market access through broader indications for use and subsequent reimbursement applications.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact